Amicus-UPenn Partnership Named ‘Deal Of The Year’ By Penn Center For Innovation

Amicus Therapeutics and Dr. James Wilson with the UPenn Gene Therapy Program are awarded Deal of the Year for their collaboration to advance AAV gene therapy research for rare metabolic disorders.